Naproxen Lowers Ossification Risk in Hip Arthroscopy

Hide

Accessibility Tools

Light Mode
Contrast Mode
Grey Mode
Increase Font Size
Decrease Font Size
Reset Font Default
Accessibility Options
Back to Main Site

In the News

Posted on: 21-Jul-2026

LAS VEGAS — The risk for heterotopic ossification after hip arthroscopy is 11 times lower when the nonsteroidal anti-inflammatory drug (NSAID) naproxen is used, a new study shows.

Read More

Source: Medscape